Comments on: HSA’s role in regulation of BMS in Singapore http://biobiz.sg/2009/02/hsas-role-in-regulation-of-bms-in-singapore/ Sparking connections Wed, 09 Mar 2011 14:31:20 +0000 hourly 1 http://wordpress.org/?v=3.3.1 By: yzlee http://biobiz.sg/2009/02/hsas-role-in-regulation-of-bms-in-singapore/comment-page-1/#comment-194 yzlee Tue, 17 Mar 2009 02:33:23 +0000 http://biobiz.sg/?p=30#comment-194 When it comes to striking a balance between over regulation and under regulation, HSA embarks on means of smart regulation. HSA main focus of drug reviews are on drugs that have little or no regulation history. In addition, drugs that have gone through rigorous reviews by other regulatory bodies like the US FDA or the European Medicine Agency will have its own review by HSA accelerated. To strengthen its regulatory capabilities, HSA have also come up with innovations that makes use of its extensive network to facilitate interactions with medical devices establishments and health care bodies. An example of this is the MEDICS@HSA system and the electronic medical record systems that HSA shares with the National Healthcare Group. This allows HSA to strengthen its surveillance capability and act swiftly on any issues. When it comes to striking a balance between over regulation and under regulation, HSA embarks on means of smart regulation. HSA main focus of drug reviews are on drugs that have little or no regulation history. In addition, drugs that have gone through rigorous reviews by other regulatory bodies like the US FDA or the European Medicine Agency will have its own review by HSA accelerated.

To strengthen its regulatory capabilities, HSA have also come up with innovations that makes use of its extensive network to facilitate interactions with medical devices establishments and health care bodies. An example of this is the MEDICS@HSA system and the electronic medical record systems that HSA shares with the National Healthcare Group. This allows HSA to strengthen its surveillance capability and act swiftly on any issues.

]]> By: <fb:name linked="false" useyou="false" uid="681090663">Ding Yi Xin</fb:name> http://biobiz.sg/2009/02/hsas-role-in-regulation-of-bms-in-singapore/comment-page-1/#comment-84 Ding Yi Xin Sat, 28 Feb 2009 16:15:48 +0000 http://biobiz.sg/?p=30#comment-84 While regulating the availability and safety of drugs is desirable, how does HSA balance this against over-regulation which may block access to key drugs, and sometimes, life-saving drugs? In view of the growing medical technology manufacturing industry regionally, how is HSA regulating the medical devices available in the market? While regulating the availability and safety of drugs is desirable, how does HSA balance this against over-regulation which may block access to key drugs, and sometimes, life-saving drugs?

In view of the growing medical technology manufacturing industry regionally, how is HSA regulating the medical devices available in the market?

]]>